Proteopedia:What's New: Difference between revisions
Eric Martz (talk | contribs) No edit summary |
Eric Martz (talk | contribs) No edit summary |
||
| Line 13: | Line 13: | ||
The left arrow symbol (<-) signifies a page that [[Help:Editing#Redirecting_One_Page_to_Another_Page|redirects]] to another page. | The left arrow symbol (<-) signifies a page that [[Help:Editing#Redirecting_One_Page_to_Another_Page|redirects]] to another page. | ||
<br><br> | <br><br> | ||
<font color="red">Because this page is maintained manually, the lists for recent months are usually incomplete. There are typically other new articles that are not yet listed.</font> You may also wish to consult [[Topic | <font color="red">Because this page is maintained manually, the lists for recent months are usually incomplete. There are typically other new articles that are not yet listed.</font> You may also wish to consult [[Topic pages]] (also maintained manually), or [[Special:Newpages]] which is automatically generated, but includes the pages for new PDB entries seeded by the OCA robot. | ||
</div> | </div> | ||
---- | ---- | ||
==June, 2010== | ==2010== | ||
===June, 2010=== | |||
*[[Metal-Ligand Polyhedra]]: Mixtures of certain metal ions with bent bidentate ligands self-assemble into large polygons that can be functionalized to serve as receptors, nanoreactors, etc. | *[[Metal-Ligand Polyhedra]]: Mixtures of certain metal ions with bent bidentate ligands self-assemble into large polygons that can be functionalized to serve as receptors, nanoreactors, etc. | ||
== May, 2010 == | === May, 2010 === | ||
*[[Rhodopsin]] | *[[Rhodopsin]] | ||
== April, 2010 == | === April, 2010 === | ||
*[[Green Fluorescent Protein]], significant additions have been made to this page. | *[[Green Fluorescent Protein]], significant additions have been made to this page. | ||
*[[NADPH Cytochrome P450 Oxidoreductase]] | *[[NADPH Cytochrome P450 Oxidoreductase]] | ||
| Line 29: | Line 30: | ||
*[[Pore forming toxin, α-hemolsyin|The pore forming toxin, α-hemolsyin]] | *[[Pore forming toxin, α-hemolsyin|The pore forming toxin, α-hemolsyin]] | ||
== March, 2010 == | === March, 2010 === | ||
*[[Serine Proteases: A Tutorial of Chymotrypsin, Trypsin and Elastase]], examines the structural basis of specificity and a general properties of the catalytic mechanism | *[[Serine Proteases: A Tutorial of Chymotrypsin, Trypsin and Elastase]], examines the structural basis of specificity and a general properties of the catalytic mechanism | ||
== January, 2010 == | === January, 2010 === | ||
*[[Archaeal Histones]], illustrates the structural features of two histones and a dimer of one of them. | *[[Archaeal Histones]], illustrates the structural features of two histones and a dimer of one of them. | ||
*[[Syn and anti nucleosides]], illustrates the structural differences in the syn and anti configurations of nucleosides. | *[[Syn and anti nucleosides]], illustrates the structural differences in the syn and anti configurations of nucleosides. | ||
| Line 38: | Line 39: | ||
*[[Ribosomal back translocase|''Escherichia coli'' LepA, the ribosomal back translocase]] | *[[Ribosomal back translocase|''Escherichia coli'' LepA, the ribosomal back translocase]] | ||
==December, 2009== | ==2009== | ||
===December, 2009=== | |||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
*[[User:Wayne Decatur/Interactions between Antibiotics and the Ribosome|Interactions between Antibiotics and the Ribosome]] | *[[User:Wayne Decatur/Interactions between Antibiotics and the Ribosome|Interactions between Antibiotics and the Ribosome]] | ||
| Line 45: | Line 47: | ||
*[[Reverse transcriptase]] | *[[Reverse transcriptase]] | ||
==November, 2009== | ===November, 2009=== | ||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
*[[1gm5|RecG in complex with a synthetic three-way DNA junction resembling a stalled replication fork]] | *[[1gm5|RecG in complex with a synthetic three-way DNA junction resembling a stalled replication fork]] | ||
*[[3ews|DExD/H-box RNA-dependent ATPase DDX19 in the open]] and [[3g0h|closed]] cleft conformation | *[[3ews|DExD/H-box RNA-dependent ATPase DDX19 in the open]] and [[3g0h|closed]] cleft conformation | ||
==October, 2009== | ===October, 2009=== | ||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
*[[Ribosome]], also featured at the [[Main Page]], since its structures won the [[Nobel Prizes for 3D Molecular Structure|Nobel Prize in Chemistry]] this month! | *[[Ribosome]], also featured at the [[Main Page]], since its structures won the [[Nobel Prizes for 3D Molecular Structure|Nobel Prize in Chemistry]] this month! | ||
| Line 57: | Line 59: | ||
*[[Proteopedia:Guidelines for Ethical Writing]] | *[[Proteopedia:Guidelines for Ethical Writing]] | ||
==July, 2009== | ===July, 2009=== | ||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
*[[Influenza hemagglutinin]] | *[[Influenza hemagglutinin]] | ||
*The 21st and 22nd amino acids were added to [[Amino Acids]]: namely [[Selenocysteine]] and [[Pyrrolysine]]. | *The 21st and 22nd amino acids were added to [[Amino Acids]]: namely [[Selenocysteine]] and [[Pyrrolysine]]. | ||
==March, 2009== | ===March, 2009=== | ||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
*[[Mechanosensitive channels: opening and closing]] includes morphs of the ion-conducting channel opening and closing. | *[[Mechanosensitive channels: opening and closing]] includes morphs of the ion-conducting channel opening and closing. | ||
| Line 68: | Line 70: | ||
*[[Richards, Frederic M.]] (1925-2009) including a photo of "Fred's Folly". | *[[Richards, Frederic M.]] (1925-2009) including a photo of "Fred's Folly". | ||
==February, 2009== | ===February, 2009=== | ||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
*[[Ion channels]] is an attempt to cover a family of proteins and list their available PDB structures. | *[[Ion channels]] is an attempt to cover a family of proteins and list their available PDB structures. | ||
==January, 2009== | ===January, 2009=== | ||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
==December, 2008== | ==2008== | ||
===December, 2008=== | |||
*[[Conservation, Evolutionary]] now includes instructions on how to show a ConSurf result as a scene in Proteopedia, complete with the standard ConSurf color key. | *[[Conservation, Evolutionary]] now includes instructions on how to show a ConSurf result as a scene in Proteopedia, complete with the standard ConSurf color key. | ||
*[[Resolution]] now includes a movie illustrating the relation between the atomic model and the electron density map while resolution ranges from 0.5 to 5.0 Ångstroms. | *[[Resolution]] now includes a movie illustrating the relation between the atomic model and the electron density map while resolution ranges from 0.5 to 5.0 Ångstroms. | ||
==November, 2008== | ===November, 2008=== | ||
*[[Suppression of RNA Silencing by Viruses|RNA silencing: suppression by viruses]]. Concerns the research awarded the [http://nobelprize.org/nobel_prizes/medicine/laureates/2006/ 2006 Nobel Prize in Physiology or Medicine]. Linked are new pages on specific RNA silencing proteins: [[Plant Viral Protein p19 Suppression of RNA Silencing|Plant viral protein p19]], [[Tomato aspermy virus protein 2b Suppression of RNA Silencing|Tomato aspermy virus protein 2b]], and [[Flock house virus B2 protein Suppression of RNA Silencing|Flock house virus B2 protein]]. | *[[Suppression of RNA Silencing by Viruses|RNA silencing: suppression by viruses]]. Concerns the research awarded the [http://nobelprize.org/nobel_prizes/medicine/laureates/2006/ 2006 Nobel Prize in Physiology or Medicine]. Linked are new pages on specific RNA silencing proteins: [[Plant Viral Protein p19 Suppression of RNA Silencing|Plant viral protein p19]], [[Tomato aspermy virus protein 2b Suppression of RNA Silencing|Tomato aspermy virus protein 2b]], and [[Flock house virus B2 protein Suppression of RNA Silencing|Flock house virus B2 protein]]. | ||
*[[Transcription Termination Factor Rho]]. | *[[Transcription Termination Factor Rho]]. | ||
| Line 87: | Line 90: | ||
*[[Molecular modeling and visualization software]], whick links to new pages on [[PyMOL]], [[Jmol]], [[RasMol]], and [[Chime]]. | *[[Molecular modeling and visualization software]], whick links to new pages on [[PyMOL]], [[Jmol]], [[RasMol]], and [[Chime]]. | ||
==October, 2008== | ===October, 2008=== | ||
*[[Lac repressor]] structure, including a morph of the DNA-binding domain bending the operator DNA. | *[[Lac repressor]] structure, including a morph of the DNA-binding domain bending the operator DNA. | ||
*Poly(A) Polymerase, [[2q66]]: A new section complementing this month's article in [[Molecule of the Month]]. | *Poly(A) Polymerase, [[2q66]]: A new section complementing this month's article in [[Molecule of the Month]]. | ||
| Line 103: | Line 106: | ||
*Several pages about visualization software: [[FirstGlance in Jmol]], [[Swiss-PDBViewer = DeepView]], and [[Protein Explorer]]. | *Several pages about visualization software: [[FirstGlance in Jmol]], [[Swiss-PDBViewer = DeepView]], and [[Protein Explorer]]. | ||
==September, 2008== | ===September, 2008=== | ||
*Anticancer Prodrug CPT-11 complexed with ''Torpedo californica'' Acetylcholinesterase [[1u65]] | *Anticancer Prodrug CPT-11 complexed with ''Torpedo californica'' Acetylcholinesterase [[1u65]] | ||
*[[Avian Influenza Neuraminidase, Tamiflu and Relenza]] | *[[Avian Influenza Neuraminidase, Tamiflu and Relenza]] | ||
| Line 113: | Line 116: | ||
*[[User:Tom Gluick/glutamine synthetase|Glutamine Synthetase]], which includes instructions on how to use the Jmol console for advanced scene authoring. | *[[User:Tom Gluick/glutamine synthetase|Glutamine Synthetase]], which includes instructions on how to use the Jmol console for advanced scene authoring. | ||
==August, 2008== | ===August, 2008=== | ||
*[[HIV-1 protease]] | *[[HIV-1 protease]] | ||
*[[Pyruvate phosphate dikinase]] with a morph of the catalytic reaction and conformational changes. | *[[Pyruvate phosphate dikinase]] with a morph of the catalytic reaction and conformational changes. | ||
| Line 123: | Line 126: | ||
*[[Proteopedia: News]] | *[[Proteopedia: News]] | ||
==July, 2008== | ===July, 2008=== | ||
*[[Biotin Protein Ligase]] | *[[Biotin Protein Ligase]] | ||
*YAGE, A Prophage Protein Belonging To The Dihydrodipicolinic Acid Synthase Family From E. Coli K12, [[2v9d]]. | *YAGE, A Prophage Protein Belonging To The Dihydrodipicolinic Acid Synthase Family From E. Coli K12, [[2v9d]]. | ||
| Line 132: | Line 135: | ||
*[[Student Projects]] | *[[Student Projects]] | ||
==June 2008== | ===June 2008=== | ||
*Computational design of a Kemp elimination catalyst [[2rkx]]. | *Computational design of a Kemp elimination catalyst [[2rkx]]. | ||
*[[Recoverin, a calcium-activated myristoyl switch]] | *[[Recoverin, a calcium-activated myristoyl switch]] | ||
| Line 160: | Line 163: | ||
*[[Unit cell]] | *[[Unit cell]] | ||
==May 2008== | ===May 2008=== | ||
*[[Acetylcholinesterase]] | *[[Acetylcholinesterase]] | ||
*[[2ace]] with an overview of the significance of this, the first acetylcholinesterase structure. | *[[2ace]] with an overview of the significance of this, the first acetylcholinesterase structure. | ||
| Line 172: | Line 175: | ||
*[[Help:Copying FirstGlance Scenes into Proteopedia]] | *[[Help:Copying FirstGlance Scenes into Proteopedia]] | ||
==April 2008== | ===April 2008=== | ||
*Acetylcholinesterase inhibited by nerve agent soman [[1som]]. | *Acetylcholinesterase inhibited by nerve agent soman [[1som]]. | ||
*Highest resolution acetylcholinesterase so far, [[1ea5]]. | *Highest resolution acetylcholinesterase so far, [[1ea5]]. | ||
| Line 183: | Line 186: | ||
*[[Help:Protected Pages]] | *[[Help:Protected Pages]] | ||
==March 2008== | ===March 2008=== | ||
*Conformational flexibility in the peripheral site of Torpedo californica acetylecholinesterase revealed by the complex structure with a bifunctional inhibitor, [[2cek]]. | *Conformational flexibility in the peripheral site of Torpedo californica acetylecholinesterase revealed by the complex structure with a bifunctional inhibitor, [[2cek]]. | ||
*[[Proton Channels]] | *[[Proton Channels]] | ||
| Line 190: | Line 193: | ||
*[[SGAP]] Streptomyces griseus Aminopeptidase (SGAP) (''no Jmol'') | *[[SGAP]] Streptomyces griseus Aminopeptidase (SGAP) (''no Jmol'') | ||
==February 2008== | ===February 2008=== | ||
*[[Hemoglobin]] | *[[Hemoglobin]] | ||
*[[Highest impact structures]] of all time. | *[[Highest impact structures]] of all time. | ||
| Line 199: | Line 202: | ||
*[[Personal favorites]] | *[[Personal favorites]] | ||
==January 2008== | ===January 2008=== | ||
*[[AChE inhibitors and substrates]] | *[[AChE inhibitors and substrates]] | ||
*[[Dihydrofolate reductase]] | *[[Dihydrofolate reductase]] | ||
==October-December 2007== | ==2007== | ||
===October-December 2007=== | |||
*[[Serine Protease]] | *[[Serine Protease]] | ||
*[[Nqo1]] NADH quinone oxidoreductase (NQO1) in complex with its potent inhibitor dicoumarol. | *[[Nqo1]] NADH quinone oxidoreductase (NQO1) in complex with its potent inhibitor dicoumarol. | ||